Preview

Tuberculosis and Lung Diseases

Advanced search

EXPERIENCE OF USING THE MINIMUM INHIBITORY CONCENTRATION METHOD ON LIQUID NUTRITIONAL MEDIA FOR DRUG SUSCEPTIBILITY TESTING OF NON-TUBERCULOUS MYCOBACTERIA

https://doi.org/10.21292/2075-1230-2017-95-8-58-62

Abstract

Goal of the study: analysis of drug resistance of certain species of non-tuberculous mycobacteria through testing by minimum inhibitory concentrations on the fluid nutritional media.

Materials and method: drug resistance of non-tuberculous mycobacteria was tested by the method of minimum inhibitory concentrations on the fluid nutritional media. 51 strains of non-tuberculous mycobacteria from the species of M. intracellulare, M. avium, M. kansasii, M. gordonae, M. fortuitum, M. abscessus were tested. The minimum inhibitory concentration of the drug for slow-growing non-tuberculous mycobacteria was defined using the panel of 13 drugs (SLOWMYCO) and for the fast-growing mycobacteria – the panel of 15 drugs RAPMYCO Sensititre (Trek Diagnostic System, Thermo Scientific, USA) was used. It was proved that the majority of tested fast growing mycobacteria were resistant to ceftriaxone, cefepime, cefoxitin but susceptible to amikacin; and slow growing non-tuberculous mycobacteria were susceptible to clarithromycin, linezolid and amikacin. 

About the Authors

O. I. Alkhovik
Novosibirsk Tuberculosis Research Institute
Russian Federation

Candidate of Medical Sciences, Junior Researcher, Bacteriologist,

81a, Okhotskaya St., Novosibirsk, 630040



T. I. Petrenko
Novosibirsk State Medical University
Russian Federation
Doctor of Medical Sciences, Professor at FPK and PPV Tuberculosis Department


References

1. Аndreevskaya S.N., Larionova E.E., Smirnova T.G., Аndrievskaya I.Yu., Kiseleva E.А., Chernousova L.N. Drug susceptibility of the slow growing non-tuberculous mycobacteria. Tuberculosis and Lung Diseases, 2016, vol. 94, no. 4, pp. 43-50.

2. Litvinov V.I., Makarova N.V., Krasnova M.А. Netuberkulyoznye mikobakterii. [Non-tuberculous mycobacteria]. Moscow, 2008, 95 p.

3. Otten T.F., Vasiliev А.V. Mikobaketerioz. [Mycobacteriosis.] St. Petersburg, Meditsinskaya Pressa Publ., 2005, 224 p.

4. Edict no. 951 by RF MoH as of 29.12.2014 On Approval of Guidelines for Improvement of Respiratory Tuberculosis Diagnostics and Treatment. (In Russ.)

5. Revyakina O.V., Аlekseeva T.V., Filippova O.P. Osnovnye pokazateli protivotuberkuleznoy deyatelnosti v Sibirskom i Dalnevostochnom federalnykh okrugakh. [Main indicators of tuberculosis control activities in Siberian and Far Eastern Federal Districts]. Novosibirsk, Sibmedizdat NGMU Publ., 2016, 92 p.

6. Chernousova L.N., Sevostyanova E.V., Larionova E.E. et al. Federal'nye klinicheskie rekomendatsii po organizatsii i provedeniyu mikrobiologicheskoy i molekulyarno-geneticheskoy diagnostiki tuberkuleza. [Federal clinical recommendations on organization and implementation of microbiological and molecular-genetic diagnostics of tuberculosis]. Tver, Triada Publ., 2015, 46 p.

7. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia and other aerobic actynomycetes; approved Standard, Second Edition. M24 – A2 Wayne, PA, CLSI, 2011, 76 p.


Review

For citations:


Alkhovik O.I., Petrenko T.I. EXPERIENCE OF USING THE MINIMUM INHIBITORY CONCENTRATION METHOD ON LIQUID NUTRITIONAL MEDIA FOR DRUG SUSCEPTIBILITY TESTING OF NON-TUBERCULOUS MYCOBACTERIA. Tuberculosis and Lung Diseases. 2017;95(8):58-62. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-8-58-62

Views: 1035


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)